발행물

전체 논문

244

11

Diastereoselective Synthesis of Cyclobutanes via Rh-Catalyzed Unprecedented C-C Bond Cleavage of Alkylidenecyclopropanes
Kim, T., Jeong, T., Chung, E., Singh, P., Rakshit, A., Park, J., Kim, I. S.*
Org. Lett., 2025

12

Discovery of 1,4-Disubstituted Cyclohexene Analogues as Selective GPR119 Agonists for the Treatment of Type 2 Diabetes
La, H., Kim, J., Kim, D.-H., Kim, S.-H., Singh, P., Nam, G., Moon, K., Kim, I., Kim, I. S.*
J. Med. Chem., 2025

13

Photoredox-Catalyzed Minisci-Type Acylation of Heterocyclic C-H Bonds with Amino Acid-Tethered Dihydropyridines
Yang, H., Shin, H., Lee, Y., Lim, D., Kwon, N. Y., Rakshit, A., Singh, P., Kim, H. J., Moon, K., Kim, I. S.*
Adv. Synth. Catal., 2025

14

Synthesis of Quinoline-Indole Hybrids through Cu(II)-Catalyzed Amination and Annulation between N-Oxides and o-Alkynylanilines
Rakshit, A., Moon, K., Singh, P., Park, J. S., Kim, I. S.*
Org. Lett., 2024

15

Urazoles as Heterocyclic Directing Groups in Ru(II)-Catalyzed Annulation of N-H/C-H Bonds with Vinylene Carbonate
Kang, J., Park, J., Singh, P., Jeong, T., Kim, I. S.*
J. Org. Chem., 2024

16

Thione-Directed C-H Amidation of Chromone Analogues with Dioxazolones Under Rh(III) Catalysis
Min, J., Park. K., Moon, K., Kim, H. S., Singh, P., Kim, I. S.*
Org. Lett., 2024

17

Therapeutic potential of bark extracts from Macaranga denticulata on renal fibrosis in streptozotocin-induced diabetic rats
Gali, S., Kundu, A., Sharma, S., Ahn, M.-Y., Puia, Z., Kumar, V., Kim, I. S., Kwak, J. H., Palit, P*, Kim, H. S.*
J. Toxicol. Environ. Health A, 2024

18

The stimulatory effect of HI 129, a novel indole derivative, on glucose-induced insulin secretion
Chau, G. C., Lim, J. E., Moon, K., Kim, I. S.*, Um, S. H.*
Biochem. Pharmacol., 2024

19

Redox-Neutral Vicarious-Type Nucleophilic Amination of Heterocyclic N-Oxides with Organic Azides
Min, J., Min, S., Chung, E., Moon, K., Kim, H. S., Jeong, T., Rakshit, A., Singh, P., Park, J. S., Kim, I. S.*
Adv. Synth. Catal., 2024

20

Discovery of 2,6-Naphthyridine Analogues as Selective FGFR4 Inhibitors for Hepatocellular Carcinoma
Oh, H., Kim, J., Jung, S. H., Ha, T. H., Ahn, Y. G., Nam, G., Moon, K., Singh, P., Kim, I. S.*
J. Med. Chem., 2024